Apyx Medical Corporation (APYX): Price and Financial Metrics

Apyx Medical Corporation (APYX)

Today's Latest Price: $10.70 USD

0.27 (-2.46%)

Updated Jan 25 4:00pm

Add APYX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 188 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

APYX Stock Summary

  • For APYX, its debt to operating expenses ratio is greater than that reported by merely 6.02% of US equities we're observing.
  • With a price/sales ratio of 15.22, Apyx Medical Corp has a higher such ratio than 87.54% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.17 for Apyx Medical Corp; that's greater than it is for merely 11.12% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Apyx Medical Corp, a group of peers worth examining would be IGC, CUTR, CDXC, NAOV, and SIBN.
  • APYX's SEC filings can be seen here. And to visit Apyx Medical Corp's official web site, go to apyxmedical.com.

APYX Stock Price Chart Interactive Chart >

Price chart for APYX

APYX Price/Volume Stats

Current price $10.70 52-week high $11.02
Prev. close $10.97 52-week low $2.81
Day low $10.43 Volume 131,200
Day high $10.93 Avg. volume 127,540
50-day MA $7.77 Dividend yield N/A
200-day MA $5.57 Market Cap 366.74M

Apyx Medical Corporation (APYX) Company Bio

Apyx Medical Corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the J-Plasma system allows surgeons to operate in eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

APYX Latest News Stream

Event/Time News Detail
Loading, please wait...

APYX Latest Social Stream

Loading social stream, please wait...

View Full APYX Social Stream

Latest APYX News From Around the Web

Below are the latest news stories about Apyx Medical Corp that investors may wish to consider to help them evaluate APYX as an investment opportunity.

Hill-Rom (HRC) to Boost Cardiology Portfolio with New Buyout

Hill-Rom's (HRC) acquisition of Bardy Diagnostics enables the former to expand into ambulatory cardiac monitoring space to accelerate digital health offering.

Yahoo | January 21, 2021

Apyx (APYX) Upgraded to Buy: Here's Why

Apyx (APYX) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Yahoo | January 18, 2021

Apyx Medical Corporation Reports Preliminary Full Year and Fourth Quarter 2020 Revenue Results

Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today reported preliminary revenue results for the full year and fourth quarter ended December 31, 2020.

Yahoo | January 13, 2021

Apyx Medical Corporation to Participate in the ICR Conference 2021

Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announced today that management will participate in the ICR Conference 2021, which is being held virtually from January 11th-14th. Management will participate in a fireside chat on Thursday, January 14th at 9:15 a.m. Eastern Time.

Yahoo | January 5, 2021

Apyx (APYX) Upgraded to Buy: Here's What You Should Know

Apyx (APYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).

Yahoo | December 15, 2020

Read More 'APYX' Stories Here

APYX Price Returns

1-mo N/A
3-mo 85.12%
6-mo 126.22%
1-year 36.83%
3-year 329.72%
5-year 393.09%
YTD 48.61%
2020 -14.89%
2019 30.56%
2018 149.23%
2017 -27.58%
2016 70.95%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7984 seconds.